152 related articles for article (PubMed ID: 12721945)
1. Phagocytosis of Bordetella pertussis incubated with convalescent serum.
Mobberley-Schuman PS; Connelly B; Weiss AA
J Infect Dis; 2003 May; 187(10):1646-53. PubMed ID: 12721945
[TBL] [Abstract][Full Text] [Related]
2. Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.
Mobberley-Schuman PS; Weiss AA
Infect Immun; 2005 Nov; 73(11):7317-23. PubMed ID: 16239529
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.
Weingart CL; Mobberley-Schuman PS; Hewlett EL; Gray MC; Weiss AA
Infect Immun; 2000 Dec; 68(12):7152-5. PubMed ID: 11083845
[TBL] [Abstract][Full Text] [Related]
4. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
[TBL] [Abstract][Full Text] [Related]
5. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.
Weingart CL; Weiss AA
Infect Immun; 2000 Mar; 68(3):1735-9. PubMed ID: 10679000
[TBL] [Abstract][Full Text] [Related]
6. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
[TBL] [Abstract][Full Text] [Related]
7. Genetic studies of the molecular basis of whooping cough.
Weiss AA; Hewlett EL; Myers GA; Falkow S
Dev Biol Stand; 1985; 61():11-9. PubMed ID: 2872097
[TBL] [Abstract][Full Text] [Related]
8. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.
Cherry JD; Xing DX; Newland P; Patel K; Heininger U; Corbel MJ
Clin Infect Dis; 2004 Feb; 38(4):502-7. PubMed ID: 14765342
[TBL] [Abstract][Full Text] [Related]
9. Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.
Colombi D; Horton DS; Oliveira ML; Sakauchi MA; Ho PL
FEMS Microbiol Lett; 2004 Nov; 240(1):41-7. PubMed ID: 15500977
[TBL] [Abstract][Full Text] [Related]
10. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
[TBL] [Abstract][Full Text] [Related]
11. Assessment of serum anti-Bordetella pertussis antibody titers among medical staff members.
Higa F; Haranaga S; Tateyama M; Hibiya K; Yamashiro T; Nakamatsu M; Tomoyose T; Nagahama M; Okamura T; Owan T; Kuda T; Kinjo F; Fujita J
Jpn J Infect Dis; 2008 Sep; 61(5):371-4. PubMed ID: 18806344
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
[TBL] [Abstract][Full Text] [Related]
13. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. I. Antibody level for B pertussis antigens in children without respiratory tract infection symptoms].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):259-68. PubMed ID: 10803255
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and by intact bacteria.
Craig FF; Lackie JM; Parton R; Freer JH
J Gen Microbiol; 1988 Aug; 134(8):2201-11. PubMed ID: 2908118
[TBL] [Abstract][Full Text] [Related]
16. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.
McGuirk P; Mills KH
Eur J Immunol; 2000 Feb; 30(2):415-22. PubMed ID: 10671196
[TBL] [Abstract][Full Text] [Related]
17. Involvement of filamentous hemagglutinin in the adherence of Bordetella pertussis to human WiDr cell cultures.
Urisu A; Cowell JL; Manclark CR
Dev Biol Stand; 1985; 61():205-14. PubMed ID: 2872106
[TBL] [Abstract][Full Text] [Related]
18. Adenylate cyclase influences filamentous haemagglutinin-mediated attachment of Bordetella pertussis to epithelial alveolar cells.
Perez Vidakovics ML; Lamberti Y; van der Pol WL; Yantorno O; Rodriguez ME
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):140-7. PubMed ID: 16965362
[TBL] [Abstract][Full Text] [Related]
19. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.
Eby JC; Gray MC; Warfel JM; Merkel TJ; Hewlett EL
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27760780
[TBL] [Abstract][Full Text] [Related]
20. Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.
Alonso JM; Rocancourt M; Le Nin S; Brezin C
Ann Sclavo Collana Monogr; 1986; 3(1-2):319-27. PubMed ID: 2892512
[No Abstract] [Full Text] [Related]
[Next] [New Search]